Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Enlyte Launches Physical Medicine Network
Enlyte on Thursday announced the launch of Apricus Physical Medicine, a network for rehabilitation services, including occupational therapy and physical therapy.
Enlyte launches specialty service for injured workers
Enlyte LLC Thursday announced the launch of Apricus Physical Medicine, a network for rehabilitation services including physical and occupational therapy.
Enlyte Launches Apricus Physical Medicine, Offering End-to-End Specialty Service Solution for Industry
New program introduces comprehensive rehabilitative services with integrated clinical oversight and continuous care coordination
Balanced Regulatory Environment: A Key Component to Unlocking the Value of Specialty Bill Review
Without the use of Specialty Bill Review (SBR), payers risk paying for errors or abuses created by providers with problematic billing practices. The regulatory climate in each state is a key component to ensuring fair and reasonable payment of medical bills especially in non-fee schedule states
Ask The Pharmacist: Understanding Skeletal Muscle Relaxants in Workers' Compensation
Skeletal muscle relaxants are a leading category of prescribed medications in workers’ compensation and elsewhere in health care, often prescribed for elderly patients and as “adjuvants” for treatment of chronic pain in patients with overlapping medical conditions and multiple medications.
Demystifying the Nuances of Specialty Bill Review Regulations
Navigate the complexities of Specialty Bill Review Regulations with Enlyte. Tune into our podcast where Trevor Davis, our Director of Regulatory Affairs, offers insights into dispute management, regulatory changes, and our strategic efforts to shape the landscape.